why choose us

First received: January 09, 2023

Clinical Trial: NAD Augmentation in Diabetes Kidney Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type2diabetes

Study Type: INTERVENTIONAL


Official Title: NAD Augmentation to Treat Diabetes Kidney Disease: A Randomized Controlled Trial

Brief Summary: A phase 2a trial randomized, double-blind, placebo-controlled, parallel group trial to determine whether NMN administration improves DKD, as indicated by a significantly greater reduction in UACR compared with placebo administration.Eligible participants will be randomized to receive either 1000 mg NMN or placebo twice daily.

Read more